Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR1 | P21453 | 2/20 | 0.35 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.34 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.34 |
| ▸ | XDH | P47989 | 1/20 | 0.33 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.33 |
| ▸ | FEN1 | P39748 | 1/20 | 0.33 |
| ▸ | ABHD6 | Q9BV23 | 1/20 | 0.32 |
| ▸ | AR | P10275 | 4/20 | 0.31 |
| ▸ | PGR | P06401 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23968855 | 0.86 | PDE2A (0.34) | ALOX5APFEN1ABHD6 | |
| SCHEMBL21917433 | 0.85 | PDE2A (0.36) | XDHALOX5APFEN1ARPGR | |
| SCHEMBL23969028 | 0.85 | PDE2A (0.36) | XDHALOX5APFEN1ARPGR | |
| SCHEMBL21917270 | 0.79 | XDH (0.40) | XDH | |
| SCHEMBL21917287 | 0.79 | CYP11B2 (0.43) | — | |
| SCHEMBL23968846 | 0.79 | CYP11B2 (0.43) | — | |
| SCHEMBL21917130 | 0.79 | KIF11 (0.49) | ARPGR | |
| SCHEMBL23969086 | 0.76 | AR (0.44) | ARPGR | |
| SCHEMBL21917138 | 0.75 | AR (0.38) | XDHARPGR | |
| SCHEMBL23968914 | 0.74 | ESR1 (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11165025-B2 | Compound and organic electronic element comprising same | LG CHEM, LTD. | 2021-11-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11165025-B2 | Compound and organic electronic element comprising same | OR10J3, ESR1, ETV6 | S1PR1 4668/4885S1PR3 4757/4885S1PR5 4750/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.